Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 11741-11750 of 13618

Page
per page
  1. Iguratimod
    A3484 Iguratimod
    Summary: COX-2 inhibitor,inhibits IL-1,IL-6,IL-8 and tumour necrosis factor.
      ≥10.9 mg/mL
  2. IRAK inhibitor 6
    A3504 IRAK inhibitor 6
    Target: IRAK
    Summary: IRAK-4 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥9.9 mg/mL
  3. JAK2 Inhibitor V, Z3
    A3514 JAK2 Inhibitor V, Z3
    Summary: Jak2 tyrosine kinase inhibitor
      Soluble in DMSO or ethanol
  4. JDTic 2HCl
    A3518 JDTic 2HCl
    Summary: κ-opioid receptor antagonist
      Soluble in DMSO
  5. JNK-IN-7
    A3519 JNK-IN-7
    Target: JNK
    Summary: Selective JNK inhibitor
      ≥24.7 mg/mL
  6. KN-92 hydrochloride
    A3530 KN-92 hydrochloride
    Target: Ca2 /calmodulin-dependent protein kinases (CaMKs)
    Summary: Inactive derivative of KN-93,control compound
      ≥24.65 mg/mL
  7. KX2-391 dihydrochloride
    A3535 KX2-391 dihydrochloride
    Target: Src
    Summary: Src kinase, tubulin polymerization, HBV transcription, and botulinum neurotoxin A (BoNT/A) inhibitor
      ≥25.2 mg/mL
  8. L-165041
    A3536 L-165041
    Target: PPAR
    Summary: PPARβ/δ agonist,cell permeable,potent and selective
      ≥40.2 mg/mL
  9. LDK378 dihydrochloride
    A3544 LDK378 dihydrochloride
    Summary: ALK inhibitor
  10. Medetomidine
    A3592 Medetomidine
     1 Citation
    Summary: α2-adrenoceptor agonist
      ≥34.5 mg/mL

Items 11741-11750 of 13618

Page
per page